Lucintel's latest market report analyzed that digital twin in the global healthcare provides attractive opportunities in the pharma& bio-pharma companies, research & academia, healthcare providers, and medical device companies. The digital twin in the global healthcare market is expected to reach $2,036.1million by 2028 with a CAGR of 26.7%. In this market, personalized medicine is the largest segment by application, whereas healthcare provider is largest by end use industry.
Based on application, the digital twin in the global healthcare market is segmented into drug discovery & development, personalized medicine, surgical planning and medical education, medical device design and testing, healthcare workflow optimization & asset management, and others. The personalized medicine segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, as they ensure enhanced patient outcomes, reduced side effects, and improved therapeutic efficacy.
Browse in-depth TOC on “Digital Twin in the Global Healthcare Market”
100 – Figures/Tables
150 – Pages
The Digital Twin in the Global Healthcare Marketis marked by the presence of several big and small players. Some of the prominent players offering digital twin in the global healthcare include Siemens Healthineers, DassaultSystèmes, Microsoft, Koninklijke Philips, Faststream Technologies, Twin Health, and IBM.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries.